# \[e-drug\] Bristol-Myers signs deal with U.N. group for generic hepatitis C drug **URL:** \ **Category:** e-drug\ **Created:** [November 23, 2015, 5:06pm UTC](https://talk.edrugplus.org/t/e-drug-bristol-myers-signs-deal-with-u-n-group-for-generic-hepatitis-c-drug/42272 "2015-11-23T17:06:15Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Lucas](https://dub1.discourse-cdn.com/flex013/user_avatar/talk.edrugplus.org/lucas/32/350_2.png) [@Lucas](https://talk.edrugplus.org/u/Lucas)\ **Post date:** [November 23, 2015, 5:06pm UTC](https://talk.edrugplus.org/t/e-drug-bristol-myers-signs-deal-with-u-n-group-for-generic-hepatitis-c-drug/42272/1 "2015-11-23T17:06:15Z")
E-DRUG: Bristol-Myers signs deal with U.N. group for generic hepatitis C drug ---------------------------------------------------------------------------------------------------------------- Health | Mon Nov 23, 2015 9:23am EST Bristol-Myers signs deal with U.N. group for generic hepatitis C drug [http://www.reuters.com/article/2015/11/23/us-bristol-myers-hepatitis-idUSKBN0TC1GD20151123?feedType=nl&feedName=healthNews#XrC768YDzE2ydfJY.97](http://www.reuters.com/article/2015/11/23/us-bristol-myers-hepatitis-idUSKBN0TC1GD20151123?feedType=nl&feedName=healthNews#XrC768YDzE2ydfJY.97) A United Nations-backed organization working to cut the price of HIV drugs said it had signed a deal with Bristol-Myers Squibb Co to allow generic versions of the company's hepatitis C drug to be sold in 112 low- and middle-income countries. The drug, Daklinza, (daclatasvir) is on the World Health Organization's list of essential medicines. Hepatitis C affects about 150 million people globally and kills around half a million each year, the World Health Organisation estimates. The Medicines Patent Pool said on Monday that Daklinza would now be available to nearly two-thirds of people affected by the disease in low- and middle-income countries. The list price in the United States for Daklinza is $63,000 for a 12-week regimen, or about $750 per day at wholesale costs, according to pharmacy benefits manager Express Scripts. Other drugs used to treat hepatitis C include Gilead Sciences' Sovaldi.(sofosbuvir) A single Sovaldi pill costs $1,000 in the United States, according to Express Scripts. The deal with Bristol-Myers allows drugmakers anywhere in the world to develop generic versions of Daklinza. The Medicines Patent Pool had earlier signed a deal with Bristol-Myers for generic versions of its HIV treatment Reyataz. (Reporting by Vidya L Nathan in Bengaluru; Editing by Ted Kerr) Read more at Reutershttp://www.reuters.com/article/2015/11/23/us-bristol-myers-hepatitis-idUSKBN0TC1GD20151123#hhwWt75HhX754y1m.99 Kind regards Lucas Heuvel 20 5101 TD Dongen (N-B) The Netherlands / Europe Lucas \